At a Glance
- PraxisPro, founded in 2023, closed a $6 million seed round led by AlleyCorp.
- The platform uses small language models trained on life-science data to coach reps before they meet healthcare providers.
- Salespeople can rehearse up to 15 typical provider interactions in an AI role-play environment.
- Why it matters: Better-prepared reps could speed access to therapies for patients who currently miss out because of ineffective commercial conversations.
News Of Philadelphia reported that ex-pharma rep Cam Badger built PraxisPro after living the problem himself: fragmented training, inconsistent coaching, and no scalable way to learn on the job.
From Sales Floor to Startup
Badger spent four years as a pharmaceutical sales representative and trainer, then joined a medical startup where he met co-founder Bhrugu Giri. The two kept seeing the same pattern-life-science sales teams that couldn’t communicate effectively with doctors. They launched PraxisPro to change that dynamic.
The company’s thesis is straightforward: sharper conversations with healthcare providers translate into more prescriptions and, ultimately, more patients receiving potentially life-changing therapies.
> “When commercial interactions with healthcare providers are ineffective, patients don’t get a fair shot at therapies that could meaningfully change their lives,” said Badger, now CEO.
AI That Knows Life-Science Rules
PraxisPro’s first product hit the market in 2025, two years after incorporation. The standalone platform also integrates into existing enterprise software and relies on small language models fed exclusively with life-science data. The resulting AI agent rehearses conversations that keep teams compliant with strict legal frameworks while sharpening their patient-focused messaging.
A typical sales cycle can involve roughly 15 separate exchanges with a provider. PraxisPro’s conversational AI lets reps practice each one, anticipate pushback, and refine responses before the real meeting.
Competitors such as Quantified and SmartWinnr offer role-play tools, but Badger claims PraxisPro’s narrow, sector-specific training data produces more realistic scenarios for pharma, medical-device, and biotech teams.
Seed Round Details
AlleyCorp led the $6 million seed round announced Wednesday. FlyBridge, South Loop Ventures, and Zeal Capital Partners also participated. Badger said the fresh capital will fund continued research and development rather than rapid hiring or marketing splurges.
The raise brings early validation to a product Badger wishes he had when he nearly lost his own sales job years ago. He clawed his way to top-performer status and now wants the platform to give other reps a faster path to competency.
> “If we can give commercial teams the ability to prepare, practice, and engage at a higher level, consistently and responsibly, then we’re not just improving commercial operations, but we’re helping ensure that innovative therapies reach the patients who need them most,” he told News Of Philadelphia.
Key Takeaways
- PraxisPro targets a narrow but high-stakes niche: life-science sales compliance and communication.
- A $6 million seed round signals investor confidence in vertical-specific AI rather than broad horizontal tools.
- Early clients gain a repeatable way to rehearse complex provider dialogues without regulatory missteps.
- Success for the startup could shorten the lag between therapy approval and patient access, addressing a gap Badger experienced firsthand.
